gene (hairy enhancer of split-related transcription factor 1) mRNA. Knockdown of Flk-1 inhibited EtOH-induced Ang-1/ Tie-2 mRNA expression and blocked EtOH-induced HCAEC network formation on Matrigel, a response that was restored by notch ligand, notch ligand delta-like ligand 4, treatment. In vivo, moderate alcohol feeding increased vascular remodeling in mouse ischemic hindlimbs. Conclusions: These data demonstrate that EtOH activates Flk-1 and Flt-1 receptors in HCAECs and promotes angiogenic activity via an Flk-1/notch pathway. These effects of EtOH may be relevant to the influence of moderate alcohol consumption on cardiovascular health.
new blood vessel formation, is essential in both normal and pathological physiology and can be beneficial or deleterious depending on the circumstance [4] . With respect to cardiovascular disease, new vessel formation following heart attack or stroke is believed desirous as it can compensate for the resulting loss of perfusion and ischemia [4] . Therefore, stimulation of angiogenesis by EtOH in the setting of atherosclerosis-induced occlusion represents a potential novel mechanism that may contribute, in part, to its cardiovascular protective effects.
Emerging evidence indicates that the notch signaling pathway plays an important role in remodeling of the adult vasculature in general, and in angiogenesis in particular [5] [6] [7] . Indeed, adult vascular endothelial cells, whose migration, proliferation, differentiation and structural rearrangement are central to the angiogenic process, express notch receptors (predominately notch 1 and 4) though little is known to date of their regulation and function in this particular cell type. In general, upon ligand binding, the notch receptor is cleaved allowing the intracellular portion to translocate to the nucleus where it derepresses transcription and modulates the expression of notch target genes that regulate cell fate decisions. These target genes include the 'hairy enhancer of split' gene and its related transcription factors (Hrts) [8, 9] . We have previously demonstrated that EtOH, at levels consistent with moderate consumption, stimulates endothelial angiogenic activity in vitro via a novel notch/angiopoietin-1 (Ang-1)/Tie-2-dependent pathway [5] .
The vascular endothelial growth factor (VEGF) family of ligands and receptors are established regulators of angiogenesis [10, 11] . VEGF-A, -B, -C and -D are ligands for receptor tyrosine kinases VEGFR1 (FMS-like tryrosine kinase 1, Flt-1) and VEGFR2 (kinase domain-containing receptor, KDR, also called fetal liver kinase 1, Flk-1). VEGF-A, the major ligand for angiogenesis, binds and activates both VEGFR1/Flt-1 and VEGFR2/Flk-1. On ligand binding, VEGFRs initiate autophosphorylation and induce tyrosine kinase activity, stimulating cellular responses including the PLCγ-PKC-Raf kinase-MEK-MAPK pathway (stimulating cell growth) and the PI3K-Akt pathway (promoting cell survival) [12] . Both stimulatory and inhibitory effects of alcohol on the VEGF-VEGFR axis have been previously reported [13, 14] . Moreover, numerous studies in mammalian cell culture and in vivo support extensive crosstalk between notch and VEGF [7, 15, 16] . Building on these reports in the literature and our previous studies, we investigated the involvement of the VEGF pathway in EtOH-stimulated endothelial cell angiogenic activity. We report here that EtOH activates Flk-1 and Flt-1 receptors and promotes angiogenic activity via an Flk-1/notch pathway. These data add new mechanistic information as to how EtOH affects vascular endothelial cells and may be relevant to the cardiovascular protective effect of moderate alcoholic beverage consumption.
Materials and Methods

Cell Culture
Human coronary artery endothelial cells (HCAECs) were obtained from Lonza (Walkersville, Md., USA) and cultured in optimized endothelial cell medium (Clonetics ® , Lonza). Cells were assessed for endothelial cell phenotype by morphology and for the expression of von Willebrand factor antigen and platelet-endothelial cell adhesion molecule. HCAECs between passages 3 and 12 were used in all experiments. EtOH (200 proof, ACS/USP grade, Pharmco Products, Brookfield, Conn., USA) was diluted in media to achieve the desired concentrations (1-50 m M ) before being added to HCAECs in culture for either 24 h (protein and mRNA expression analysis) or 5-30 min (receptor activation experiments) as indicated. Alternatively, HCAECs were treated with hrVEGF165 (30 ng/ml, R & D Systems, Minneapolis, Minn., USA) for 5-30 min.
Quantitative Real-Time RT-PCR
Total RNA (0.5-1 μg), isolated from cells using a Qiagen RNeasy kit (Valencia, Calif., USA) was reverse-transcribed using an iscript TM cDNA synthesis kit from Bio-Rad (Carlsbad, Calif., USA). The gene-specific oligonucleotide sequences were designed using NCBI/Primer blast and primers that specifically spanned exon-exon junctions, utilized to eliminate genomic DNA contamination. Comparative Ct analysis using SYBER green-based real-time RT-PCR was performed where calibrator controls were selected using the Stratagene MX3005 machine and the SYBER green jumpstart PCR kit (Sigma, St. Louis, Mo., USA) as described by the manufacturer.
Western Blot Analysis
Proteins from cell lysates (12-15 μg) were resolved on sodium dodecyl sulfate polyacrylamide gel electrophoresis (12% resolving, 5% stacking) prior to transfer onto nitrocellulose membranes (Amersham Biosciences, Piscataway, N.J., USA). Membranes were stained with Ponceau S and probed for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) to ensure equal protein loading and transfer and rinsed in wash buffer (PBS containing 0.05% Tween-20) before being probed using commercially available antibodies from Abcam (Cambridge, Mass., USA). All primary antibody dilutions were 1: 500 (overnight) with corresponding 1: 10,000 secondary dilutions (2 h). Following secondary antibody incubation, membranes were rinsed in wash buffer (PBS containing 0.05% Tween-20) before being stained with Clarity TM ECL Western Substrate Solution (Bio-Rad). Membranes were then analyzed for protein expression using the Chemidoc TM XRS+ system (BioRad). Band Intensity was quantified and normalized for protein concentration (GAPDH) using the Image Lab TM software (BioRad).
Angiogenic Activity (Network Formation on Matrigel)
Ninety-six-well tissue culture plates were coated with BD Matrigel TM (100 μl/well, Becton-Dickinson, Franklin Lakes, N.J., USA), which was allowed to solidify at 37 ° C for 30 min before plating the cells. HCAECs (3 × 10 3 cells), which had been treated with or without EtOH for 24 h, were then plated at 125 μl/well onto the surface of the Matrigel and incubated at 37 C. After 16 h, the cells were photographed with the use of a CCD digital camera (Spot RT, Diagnostics Instruments Inc., Sterling Heights, Mich., USA) at a magnification of ×4. Network formation was quantified by measuring the length of the network of connected cells in each well by drawing a line over them and measuring the length of the line in pixels with the use of SpotSoftware Version 4.6 (Diagnostic Instruments Inc.) essentially as described by us previously [5, 17] . In parallel experiments, angiotensin-1 and Tie-2 mRNA and protein expression was also determined as an additional measurement of angiogenic activity. 
Small Interfering RNA Transfection
Alcohol Gavage
Eight-to 10-week-old male C57BL6 mice were divided into 2 groups: 'control' and 'moderate EtOH'. For 1 week the moderate EtOH group received by oral gavage 0.8 g/kg of 200 proof EtOH in a total volume of 200 μl water, giving a peak blood alcohol concentration of approximately 15 m M [18] , whereas the control group was gavaged daily with an isocaloric water/cornstarch mixture. After the 1-week equilibration period, hindlimb ischemia was achieved in all mice (as described below), and the control or alcohol feeding regimens continued up to 7 days after surgery.
Hindlimb Ischemia
Hindlimb ischemia was achieved in mice by unilateral ligation of the femoral artery [19] . The common femoral artery was ligated twice proximal to the popliteal and the caudal femoral arteries. The epigastric artery was also ligated. After confirming successful limb ischemia by checking the severe paleness of the foot, the overlying skin was closed with sutures.
Monitoring of Hindlimb Blood Flow
Before and on days 3 and 7 after femoral ligation, the ischemic (right)/normal (left) limb blood flow ratio was measured by use of a Moor Infrared Laser Doppler Imager (MOORLDI12-IR, Moor Instruments Inc., Wilmington, Del., USA). Before scanning was initiated, mice were placed on a heating plate at 37 ° C to minimize temperature variation. After laser Doppler color images had been recorded twice, the average perfusion of the ischemic and nonischemic limbs was calculated on the basis of colored histogram pixels. The data was analyzed with Moor laser Doppler image processing software V3.09. Perfusion was expressed as the ratio of flow in the ischemic/nonischemic hindlimb after background subtraction.
Data Analysis
Results are expressed as means ± SEM. Experimental points were performed in triplicate, with a minimum of 3 independent experiments. For the hindlimb ischemia study, 4-6 mice were used per experimental point. An analysis of variance test was performed on network formation data, and a Wilcoxon signed rank test was used for comparison of two groups when compared to the normalized control. A value of p ≤ 0.05 was considered significant.
Results
Ethanol Increases Expression and Activates Flk-1 in HCAECs
Exposure of HCAECs to ethanol (EtOH 1-50 m M , 24 h) did not affect VEGF-A levels (data not shown), but dose-dependently increased Flk-1 (i.e. VEGFR2) expression in the moderate range up to 25 m M while showing only a subtle increase at the higher dose of 50 m M ( fig. 1 ). fig. 2 ) . Interestingly, combined EtOH/VEGF treatment at the same concentrations and time showed no effect on Flk-1 activation ( fig. 2 ) . The VEGF receptor inhibitor SU5416 significantly attenuated the EtOH-induced Flk-1 receptor activation ( fig. 2 c) . In parallel cultures, EtOH treatment stimulated Akt, as indicated by increased Akt Ser473 phosphorylation, to an extent greater than the stimulation by VEGF treatment ( fig. 2 b) . In addition, there was no increase in p-Akt, compared to control, with combined EtOH/VEGF treatment ( fig. 2 d) .
Flk-1 Knockdown Inhibits EtOH-Stimulated Notch Signaling in HCAECs
We previously reported that EtOH stimulates notch expression and signaling in human umbilical vein endothelial cells [5] . Gene silencing of Flk-1 in HCAECs with specific targeted siRNA duplexes was confirmed at the mRNA and protein level: >80% decrease in Flk-1 mRNA and protein expression when compared to scrambled controls ( fig. 3 a, b) . Flk-1 siRNA significantly decreased notch receptors 1 and 4, and notch target gene Hrt-1 mRNA in control, untreated HCAECs ( fig. 3 c) . Moreover, Flk-1 knockdown strongly attenuated EtOH-induced notch 1 and 4 and Hrt-1 mRNA expression in these cells ( fig. 3 c) .
EtOH-Induced Angiogenic Response Is Flk-1 Dependent
EtOH treatment (25 m M , 24 h) significantly stimulated HCAEC angiogenic activity as indicated by increased network formation on Matrigel ( fig. 4 ) . As an in vivo correlate, we used the mouse hindlimb ischemia model. There was significantly greater perfusion in the ischemic hindlimbs of moderately EtOH-gavaged mice compared to controls, 3 and 7 days after femoral artery ligation, as determined by laser Doppler imaging ( fig. 5 ) , indicative of increased vascular remodeling which may include angiogenesis. Knockdown of Flk-1 with siRNA attenuated network formation, compared to cells treated with scrambled RNA control, and completely inhibited EtOH-stimulated HCAEC network formation ( fig. 4 a, b) . Moreover, Flk-1 siRNA reduced Ang-1 and Tie-2 mRNA expression in control HCAECs by 51.0 ± 5% and 50.0 ± 7%, respectively, and completely inhibited EtOH-induced Ang-1/ Tie-2 mRNA expression ( fig. 4 c) . 
Flk-1 Mediates EtOH-Stimulated HCAEC Angiogenic Activity via a Notch-Dependent Pathway
Treatment with notch Dll4 (2.0 μg, 24 h) partly recovered the Flk-1 siRNA inhibition of EtOH-induced network formation ( fig. 6 ). In parallel cultures, treatment with notch Dll4 recovered the Flk-1 siRNA inhibition of EtOH-induced expression of notch 1 and 4 and Ang-1/ Tie-2 mRNA. These data indicate that Flk-1 mediates EtOH-stimulated HCAEC notch signaling and angiogenic activity, and that notch is downstream of VEGF.
Discussion
While heavy and/or binge drinking is deleterious to health, epidemiological studies describe moderate or 'low-risk' drinking (defined for women as no more than 3 drinks on any single day and no more than 7 drinks per week; National Institute of Alcohol Abuse and Alcoholism) as a negative risk factor for atherosclerosis and its clinical consequences, heart attack and stroke [3] . In the USA, 1 unit of alcohol (i.e. 12 oz of beer, 5 oz of wine or 1.5 oz of liquor) contains 14 g of pure alcohol. Moderate alcohol consumption in the range of 1-3 drinks/day gives rise to blood alcohol levels of 5-25 m M [1, 20] . The main type of alcohol found in alcoholic beverages is EtOH, and a better understanding of the cellular and molecular mechanisms mediating its effects is beginning to emerge. Here we report that EtOH, at concentrations found in moderate drinkers, increases angiogenesis in vivo and stimulates the expression and activation of the VEGFR Flk-1/KDR in cultured human coronary artery endothelial cells in vitro. Moreover, Flk-1 is critical in mediating EtOH-stimulated notch signaling and subsequent angiogenic activity in these cells. These effects of EtOH may be relevant to the influence of moderate alcohol consumption on cardiovascular health.
Migration and proliferation of endothelial cells is critical to angiogenesis which is associated with a variety of pathologies and can be beneficial or harmful, depending on the clinical situation [4] . Thus, control of angiogenesis represents an area of considerable therapeutic potential. With regard to cardiovascular disease, the role of angiogenesis is complex and context-dependent. For example, atherosclerotic plaque angiogenesis seems to characterize the inflammatory, more vulnerable plaque, and a positive association between neovessel density and plaque rupture has been reported [21] . In contrast, coronary collateral angiogenesis in response to occlusion ischemia can compensate for loss of perfusion following myocardial infarct or stroke and in this way can protect tissues from ischemic damage [22, 23] factors responsible for this variation unclear. An understanding of the contributing causes, which may include genetic elements or lifestyle habits such as drinking, is therefore desirable. Indeed, recent research studies support a modulatory effect of alcohol consumption on neovessel formation in the heart. Lassaletta et al. [26] reported that diet supplementation with moderate doses of EtOH increased arteriolar density and improved myocardial perfusion in chronically ischemic swine myocardium. Louboutin et al. [27] reported in a rat model that alcohol feeding stimulated VEGF production, increased the number of capillaries in the heart and protected the heart from myocardial ischemia/reperfusion injury. The effects of EtOH in that study were inhibited by VEGFneutralizing antibody [27] . Similarly, our data in the hindlimb ischemia mouse model suggests that EtOH feeding increases vascular remodeling in response to ischemia, which is usually a combination of arteriogenesis and angiogenesis, as indicated by significantly greater perfusion after ligation in the moderate EtOH-fed group compared to controls (no alcohol). In apparent contrast, EtOH consumption reportedly diminished the protective effect of estrogen on infarct size and myocardial capillary density in ovariectomized mice [28] . Despite these contradictory reports, available evidence supports a modulatory effect of alcohol on angiogenesis in the heart. Several other groups have also investigated the effect of EtOH on angiogenesis, not only in the context of cardiovascular disease, but also in tumorigenesis and wound healing, in a variety of in vitro and in vivo models. We previously reported that EtOH, at levels consistent with moderate consumption, stimulated endothelial cell growth and migration, key processes in angiogenesis [5] .
In that study, EtOH promoted angiogenic activity in human umbilical vein endothelial cells by stimulating a novel notch/Ang-1 pathway [5] . These in vitro data, and the new data in HCAECs presented here, are in general agreement with the in vivo studies mentioned above demonstrating a stimulatory effect of alcohol consumption on myocardial neovessel development [26, 27] and with several other studies reporting a stimulatory effect of EtOH on angiogenesis, some looking at tumor angiogenesis [13, [29] [30] [31] . At least one group describes an inhibitory effect of EtOH on angiogenesis in the context of wound healing [14, 32] . These apparently contradictory findings are likely due to differing experimental doses, exposure times and/or models used. Nevertheless, our data support a stimulatory effect of ethanol on endothelial cell (both human umbilical vein endothelial cells and HCAECs) angiogenic activity as determined by a Matrigel in vitro angiogenesis assay which models the tube formation 'morphogenesis' stage of angiogenesis [33] .
The VEGF family of ligands and receptors are established regulators of angiogenesis [10, 11] and both stimu- latory and inhibitory effects of EtOH on VEGF have been reported [13, 27, 32] . Given that there is evidence of extensive crosstalk between notch and VEGF signaling pathways [7, 15, 16, [34] [35] [36] , we investigated the possibility that stimulation of notch and subsequent angiogenesis in endothelial cells by EtOH is mediated via its effect on VEGF. EtOH dose-dependently increased Flk-1 expression, in the absence of any effect on VEGF-A levels, and activated Flk-1 and downstream Akt. Gene knockdown experiments illustrated the critical requirement for Flk-1 in mediating the EtOH-induced notch signaling and endothelial angiogenic response. Moreover, treatment with a notch ligand partly recovered the EtOH notch and angiogenic responses in cells in which Flk-1 was knocked down illustrating the directional hierarchy of the pathway, i.e. VEGF upstream of notch. While others have also demonstrated a stimulatory effect of EtOH on VEGF and on VEGF receptor expression [13, 37, 38] , few have reported whether EtOH acts to stimulate Flk-1 receptor activation like our data indicate. Precisely how EtOH activates Flk-1, an effect blocked by the VEGFR inhibitor SU5416, is not clear at present. Of note EtOH stimulates endothelial nitric oxide synthase activity resulting in increased nitric oxide [39] . Nitric oxide has previously been reported to cause Flk-1 receptor phosphorylation in cardiomyocytes [40] . Thus, EtOH activation of the Flk-1 receptor in HCAECs could be an indirect effect via nitric oxide. Moreover, we found it interesting that despite their individual stimulatory effects, a combination of both EtOH and VEGF had essentially no effect on Flk-1 receptor activation/autophosphorylation. The reasons for this unexpected result are not obvious at present. It is possible that some direct chemical interaction occurs between the two agonists that negates an agonist effect of either at the Flk-1 receptor. Alternatively, because EtOH promotes the proangiogenic action of Ang-1 and angiopoietins have been shown to inhibit VEGF-A actions in endothelial cells [41] , it is also possible that Ang-1 inhibits VEGF activation of Flk-1 when EtOH is present. Further investigation is warranted to fully understand this effect.
In conclusion, our findings illuminate a critical role for the VEGFR2 (Flk-1/KDR) in mediating the stimulatory effect of EtOH on notch signaling and subsequent angiogenic activity in HCAECs. This mechanistic information adds to our understanding of how alcohol affects vascular endothelial cells whose function is critical not only in angiogenesis, but also in vascular homeostasis and vascular pathologies such as atherosclerosis.
